At UNSW Sydney, researchers wielding the molecular precision of CRISPR have uncovered why a rare few born with sickle cell disease never suffer its cruelties — a single small deletion in the genome quietly keeps a protective fetal protein switched on for life. The discovery, emerging from the genomes of naturally protected patients and confirmed in laboratory cell lines, offers not merely an answer to a decades-old mystery but a potential map toward therapies for the 318,000 infants born each year into this inherited burden. In finding one unified mechanism where many had assumed chaos, scienc
News-Medical.net
· Apr 09, 2022
· health
· 4 min de lectura
High
Verificación: Verificado
UNSW researchers use CRISPR to unlock sickle cell disease mechanism
Sickle cell disease and beta thalassemia cause 3% of deaths in children under five worldwide, with over 318,000 infants born annually with these conditions.
◉
Science & Space
6944 artículos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% coincidencia
NASA fuels Artemis II for historic moon mission with four-astronaut cr…
The Atlanta Journal-Constitution · 99% coincidencia
NASA Fuels Artemis II for Historic Lunar Return with Diverse Crew
Devdiscourse · 99% coincidencia
Cleveland's NASA Glenn drives moon base tech for Artemis lunar mission…
cleveland.com · 99% coincidencia
Caltech Researchers Solve Mystery of Lunar Tremors: Thermal Expansion …
Hot Hardware · 99% coincidencia
Cobertura Relacionada
The Guardian · Aug 23
British firm trafficked enslaved Africans 40 years after abolition, letter reveals
Evidence reveals Sandbach, Tinne and Company illegally trafficked enslaved Africans to Guyana in 1847, four decades afte…
Space Daily · Aug 23 Webb finds Neptune's upper atmosphere far colder than Voyager measured 34 years agoWebb's 2023 observations reveal Neptune's upper atmosphere is 358K, far colder than Voyager 2's 1989 measurement of 750K…
Science Daily · Aug 23 Fast-spinning stars survive black hole encounters, revealing why their flares fadeAstronomers discovered that stars with rapid pre-existing rotation survive repeated close encounters with supermassive b…
Indian Aerospace and Defence Bulletin · Aug 23 India Charts Course for Sustainable Space Operations Amid Orbital Debris CrisisIndia launches initiatives to prevent orbital debris and establish sustainable space operations, including ISRO's Debris…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
UNSW CRISPR research advances sickle cell disease understanding with therapeutic implications, primarily benefiting medical science rather than geopolitical dynamics.
Escalation Risk
low
Confidence
HIGH
No significant geopolitical power shifts. This is biomedical research with potential humanitarian benefits, particularly for tropical regions with high disease prevalence. Australia-US scientific collaboration continues existing research partnerships.
Lente Económico
📈
UNSW CRISPR research identifies genetic mechanism in sickle cell disease, potentially enabling new therapeutics and supporting biotech sector growth in gene editing and rare disease treatment.
Market Signal
bullish
Confidence
MED
Biotechnology and gene therapy
Pharmaceutical and drug development
Healthcare and medical devices
Research and development
Rare disease treatment
Patients with sickle cell disease and beta thalassemia may eventually access more effective treatments, reducing healthcare costs and improving quality of life. Broader population benefits from advancing gene-editing technology applications.
Governments may increase funding for rare disease research and gene therapy development. Regulatory frameworks for CRISPR-based therapeutics will likely evolve. Patent and IP protections for gene-editing innovations may be strengthened. Healthcare systems may need to prepare for potential high-cost gene therapies.